Market Overview

8 Biggest Price Target Changes For Monday

Share:
Related TROV
Mid-Afternoon Market Update: Coherus Biosciences Drops After FDA Response Letter; TrovaGene Shares Surge
15 Biggest Mid-Day Gainers For Monday
Related NVDA
There Could Be 18% Upside Left In Nvidia, Analyst Says
8 Biggest Price Target Changes For Friday
15 Current Wall Street Favorites - Cramer's Mad Money (11/20/17) (Seeking Alpha)

 

  • Credit Suisse lowered the price target on Bristol-Myers Squibb Co (NYSE: BMY) from $86 to $63. Bristol-Myers Squibb shares closed at $63.28 on Friday.
  • Jefferies boosted the price target for NVIDIA Corporation (NASDAQ: NVDA) from $56 to $69. NVIDIA shares closed at $58.20 on Friday.
  • Goldman Sachs boosted the price target for BlackRock, Inc. (NYSE: BLK) from $390 to $400. BlackRock shares closed at $374.75 on Friday.
  • Cantor Fitzgerald raised the price target on TrovaGene Inc (NASDAQ: TROV) from $5 to $7. TrovaGene shares closed at $5.20 on Friday.
  • Citi increased Raptor Pharmaceutical Corp. (NASDAQ: RPTP) price target from $6 to $8. Raptor Pharmaceutical shares closed at $6.89 on Friday.
  • CLSA increased Reynolds American, Inc. (NYSE: RAI) price target from $52 to $54. Reynolds American shares closed at $48.92 on Friday.
  • UBS raised Ferrari N.V. (NYSE: RACE) price target from $50 to $53. Ferrari shares closed at $46.88 on Friday.
  • Credit Suisse raised the price target for Merck & Co., Inc. (NYSE: MRK) from $62 to $73. Merck shares closed at $63.86 on Friday.

Latest Ratings for TROV

DateFirmActionFromTo
Nov 2017Maxim GroupDowngradesBuyHold
Mar 2017PiperJaffrayDowngradesNeutralUnderweight
Aug 2016Cantor FitzgeraldUpgradesHoldBuy

View More Analyst Ratings for TROV
View the Latest Analyst Ratings

Posted-In: Price Target ChangesPrice Target Analyst Ratings

 

Related Articles (BLK + BMY)

View Comments and Join the Discussion!

Partner Center